Opportunistic infections complicating immunotherapy for non‐small cell lung cancer

Immunotherapy has produced durable responses in numerous advanced and metastatic cancers, especially advanced non‐small cell lung carcinoma (NSCLC). However, opportunistic infection has become a major risk for patients who have received immune checkpoint inhibitors (ICIs). Early diagnosis of infecti...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Thorac Cancer
Autors principals: Liu, Ziwei, Liu, Tao, Zhang, Xiaotong, Si, Xiaoyan, Wang, Hanping, Zhang, Jingjia, Huang, Hui, Sun, Xuefeng, Wang, Jinglan, Wang, Mengzhao, Zhang, Li
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons Australia, Ltd 2020
Matèries:
Brief Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7262884/
https://ncbi.nlm.nih.gov/pubmed/32311221
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13422
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars